KY-3

N/A

Report date: 2022/09/23 15:32:56
NME

Base Information

Drug NameKY-3
Drug Alias NameKY-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA helicases inhibitors
TargetsRNA helicases
Therapy Area/IndicationsAdenocarcinoma of Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen KeYe Life Technologies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen KeYe Life Technologies Co Ltd
Inactive CompaniesN/A
Active IndicationsAdenocarcinoma of Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A